Why Eli Lilly chose Cipla to market Mounjaro under a new brand name for India

Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, respectively.

from Business News: Get Latest Business News Today along with Share Market updates and Indian Stock Market News | Hindustan Times https://ift.tt/6c57nAz